nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—Injection site pain—Furosemide—dilated cardiomyopathy	0.0481	0.0606	CcSEcCtD
Sufentanil—Urinary retention—Furosemide—dilated cardiomyopathy	0.0271	0.0342	CcSEcCtD
Sufentanil—Confusional state—Spironolactone—dilated cardiomyopathy	0.026	0.0327	CcSEcCtD
Sufentanil—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0258	0.0325	CcSEcCtD
Sufentanil—Somnolence—Spironolactone—dilated cardiomyopathy	0.0229	0.0289	CcSEcCtD
Sufentanil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0212	0.0267	CcSEcCtD
Sufentanil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0204	0.0257	CcSEcCtD
Sufentanil—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0203	0.0256	CcSEcCtD
Sufentanil—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0195	0.0245	CcSEcCtD
Sufentanil—Urethral disorder—Furosemide—dilated cardiomyopathy	0.0193	0.0244	CcSEcCtD
Sufentanil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.019	0.0239	CcSEcCtD
Sufentanil—Pruritus—Spironolactone—dilated cardiomyopathy	0.0182	0.023	CcSEcCtD
Sufentanil—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0182	0.0229	CcSEcCtD
Sufentanil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0176	0.0222	CcSEcCtD
Sufentanil—Erythema—Furosemide—dilated cardiomyopathy	0.0172	0.0216	CcSEcCtD
Sufentanil—Dizziness—Spironolactone—dilated cardiomyopathy	0.017	0.0215	CcSEcCtD
Sufentanil—Vomiting—Spironolactone—dilated cardiomyopathy	0.0164	0.0206	CcSEcCtD
Sufentanil—Rash—Spironolactone—dilated cardiomyopathy	0.0162	0.0205	CcSEcCtD
Sufentanil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0162	0.0204	CcSEcCtD
Sufentanil—Headache—Spironolactone—dilated cardiomyopathy	0.0161	0.0203	CcSEcCtD
Sufentanil—Nausea—Spironolactone—dilated cardiomyopathy	0.0153	0.0193	CcSEcCtD
Sufentanil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0151	0.019	CcSEcCtD
Sufentanil—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.0146	0.0184	CcSEcCtD
Sufentanil—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0145	0.0183	CcSEcCtD
Sufentanil—Confusional state—Furosemide—dilated cardiomyopathy	0.0141	0.0178	CcSEcCtD
Sufentanil—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.014	0.0177	CcSEcCtD
Sufentanil—Chills—Lisinopril—dilated cardiomyopathy	0.0133	0.0167	CcSEcCtD
Sufentanil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.0132	0.0167	CcSEcCtD
Sufentanil—Hypotension—Furosemide—dilated cardiomyopathy	0.0131	0.0165	CcSEcCtD
Sufentanil—Erythema—Lisinopril—dilated cardiomyopathy	0.0129	0.0162	CcSEcCtD
Sufentanil—Somnolence—Furosemide—dilated cardiomyopathy	0.0125	0.0157	CcSEcCtD
Sufentanil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0115	0.0146	CcSEcCtD
Sufentanil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0111	0.014	CcSEcCtD
Sufentanil—Confusional state—Lisinopril—dilated cardiomyopathy	0.0106	0.0134	CcSEcCtD
Sufentanil—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0105	0.0133	CcSEcCtD
Sufentanil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0103	0.013	CcSEcCtD
Sufentanil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0103	0.0129	CcSEcCtD
Sufentanil—Pruritus—Furosemide—dilated cardiomyopathy	0.00991	0.0125	CcSEcCtD
Sufentanil—Hypotension—Lisinopril—dilated cardiomyopathy	0.00982	0.0124	CcSEcCtD
Sufentanil—Somnolence—Lisinopril—dilated cardiomyopathy	0.00935	0.0118	CcSEcCtD
Sufentanil—Dizziness—Furosemide—dilated cardiomyopathy	0.00927	0.0117	CcSEcCtD
Sufentanil—Vomiting—Furosemide—dilated cardiomyopathy	0.00891	0.0112	CcSEcCtD
Sufentanil—Rash—Furosemide—dilated cardiomyopathy	0.00883	0.0111	CcSEcCtD
Sufentanil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00883	0.0111	CcSEcCtD
Sufentanil—Headache—Furosemide—dilated cardiomyopathy	0.00878	0.0111	CcSEcCtD
Sufentanil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00866	0.0109	CcSEcCtD
Sufentanil—Nausea—Furosemide—dilated cardiomyopathy	0.00832	0.0105	CcSEcCtD
Sufentanil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00831	0.0105	CcSEcCtD
Sufentanil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00775	0.00976	CcSEcCtD
Sufentanil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00744	0.00937	CcSEcCtD
Sufentanil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00695	0.00876	CcSEcCtD
Sufentanil—Vomiting—Lisinopril—dilated cardiomyopathy	0.00668	0.00842	CcSEcCtD
Sufentanil—Rash—Lisinopril—dilated cardiomyopathy	0.00663	0.00835	CcSEcCtD
Sufentanil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00662	0.00835	CcSEcCtD
Sufentanil—Headache—Lisinopril—dilated cardiomyopathy	0.00659	0.0083	CcSEcCtD
Sufentanil—Nausea—Lisinopril—dilated cardiomyopathy	0.00624	0.00787	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00529	0.0256	CbGpPWpGaD
Sufentanil—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00492	0.0238	CbGpPWpGaD
Sufentanil—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00464	0.0225	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00464	0.0225	CbGpPWpGaD
Sufentanil—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00432	0.0209	CbGpPWpGaD
Sufentanil—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00407	0.0197	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00407	0.0197	CbGpPWpGaD
Sufentanil—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00392	0.019	CbGpPWpGaD
Sufentanil—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00365	0.0177	CbGpPWpGaD
Sufentanil—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00357	0.0173	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00344	0.0167	CbGpPWpGaD
Sufentanil—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00302	0.0146	CbGpPWpGaD
Sufentanil—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00291	0.0141	CbGpPWpGaD
Sufentanil—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00283	0.0137	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00249	0.0121	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00249	0.0121	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00231	0.0112	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00218	0.0106	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00218	0.0106	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0021	0.0102	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0021	0.0102	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00203	0.00983	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00195	0.00945	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00195	0.00944	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00194	0.00938	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00191	0.00927	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00185	0.00893	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00185	0.00893	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00184	0.00892	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00184	0.00892	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00181	0.00877	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00176	0.0085	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00172	0.00831	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00171	0.00829	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00171	0.00828	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00168	0.00813	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00167	0.00809	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00167	0.00809	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00159	0.00769	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00156	0.00754	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00156	0.00754	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00155	0.00752	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00154	0.00745	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0015	0.00728	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0015	0.00726	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00146	0.00709	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00146	0.00709	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00145	0.00701	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00144	0.00699	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00142	0.00689	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00142	0.00687	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00136	0.00659	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00135	0.00652	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00134	0.0065	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00132	0.00638	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00131	0.00636	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0013	0.0063	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00128	0.00622	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00127	0.00616	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00127	0.00616	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00126	0.0061	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00125	0.00604	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00124	0.00599	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00124	0.00599	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00122	0.0059	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00118	0.00572	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00118	0.00572	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00115	0.00557	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00115	0.00554	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00114	0.0055	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00113	0.00545	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00112	0.0054	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00112	0.0054	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00111	0.0054	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00111	0.00538	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00107	0.00517	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00105	0.0051	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00104	0.00502	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.001	0.00486	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000998	0.00483	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000997	0.00483	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000978	0.00473	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000952	0.00461	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000943	0.00456	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000943	0.00456	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000928	0.00449	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000904	0.00438	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000903	0.00437	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000876	0.00424	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000858	0.00415	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000849	0.00411	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000842	0.00408	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000814	0.00394	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000792	0.00384	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000725	0.00351	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000719	0.00348	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000719	0.00348	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000688	0.00333	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000688	0.00333	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00067	0.00324	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000668	0.00324	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000653	0.00316	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000653	0.00316	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000647	0.00313	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00063	0.00305	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00063	0.00305	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000607	0.00294	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000603	0.00292	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000588	0.00285	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000586	0.00284	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000572	0.00277	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000572	0.00277	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000567	0.00275	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000553	0.00268	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000533	0.00258	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000533	0.00258	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000532	0.00258	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000524	0.00254	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000515	0.00249	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00051	0.00247	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000502	0.00243	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000495	0.0024	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000485	0.00235	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000484	0.00234	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000484	0.00234	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00048	0.00232	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000476	0.00231	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00046	0.00223	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00045	0.00218	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00044	0.00213	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000435	0.00211	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000434	0.0021	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000417	0.00202	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00041	0.00198	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000407	0.00197	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000389	0.00188	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000389	0.00188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000386	0.00187	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000386	0.00187	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000381	0.00184	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000372	0.0018	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00037	0.00179	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000358	0.00174	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000357	0.00173	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000353	0.00171	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000353	0.00171	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000347	0.00168	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000341	0.00165	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000338	0.00164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000338	0.00164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000324	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000322	0.00156	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000314	0.00152	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00031	0.0015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000304	0.00147	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000302	0.00146	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000296	0.00144	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000288	0.0014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000286	0.00138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000286	0.00138	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000281	0.00136	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000274	0.00133	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000266	0.00129	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000264	0.00128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000262	0.00127	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00026	0.00126	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000257	0.00125	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000248	0.0012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000247	0.00119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000245	0.00119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000242	0.00117	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000224	0.00109	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00022	0.00106	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000218	0.00106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000215	0.00104	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000212	0.00103	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000209	0.00101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000208	0.00101	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000191	0.000927	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000183	0.000886	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000182	0.000879	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000179	0.000867	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000168	0.000814	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000162	0.000783	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000155	0.000749	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000147	0.000714	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000145	0.000701	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000127	0.000615	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000125	0.000603	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000107	0.00052	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.93e-05	0.000481	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.71e-05	0.000422	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.36e-05	0.000356	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.09e-05	0.000295	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.94e-05	0.000287	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.34e-05	0.000259	CbGpPWpGaD
